NEWS
View news from our Featured Companies.
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023
PORTLAND, Maine, Jan. 08, 2024 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
Mogo Portfolio Company WonderFi Provides Corporate Update
With over 1.6 million users and $1 billion in client AUC, WonderFi is one of the largest crypto exchange platforms in Canada Mogo holds ~87 million shares in TSX listed WonderFi TORONTO - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), one of Canada's...
SenesTech Partners with Global Leader in Irrigation Solutions to Expand Evolve™ Soft Bait to Open Field Agriculture Applications
PHOENIX, Jan. 8, 2024 -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces the expansion of EvolveTM, its innovative soft bait fertility control solution, into the broader...
Dror Ortho-Design, Inc. Files Three New Patents for its AI Based Smile Correction Solution
NEW YORK, NY / January 8, 2024 / Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK:DROR), an AI-based orthodontic platform company that has developed a proprietary solution to correct people's smiles by straightening teeth using pulsating air delivered by a...
PolyPid Announces Private Placement for $16 Million in Gross Proceeds
Financing Led by Leading U.S. Life Sciences-focused InvestorsPETACH TIKVA, Israel, Jan. 04, 2024 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it has entered into a...
Cadrenal Therapeutics to Present at the Biotech Showcase on January 8, 2024 Alongside the J.P. Morgan Annual Healthcare Conference
PONTE VEDRA, Fla., Jan. 4, 2024 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes and deaths due to blood...
Reviva Provides Corporate and Program Updates and Highlights Key Upcoming Milestones
- Schizophrenia late-stage clinical program advances with positive topline Phase 3 data, successful ongoing enrollment in open label extension (OLE) trial, and positive drug-drug interaction data supporting a differentiated profile for once-daily brilaroxazine - -...
Mogo’s Digital Payments Subsidiary, Carta Worldwide, Reports 36% Increase in Payments Volume in 2023 to $9.9 Billion
TORONTO - Carta Worldwide ("Carta"), a global digital payments business owned and operated independently by Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO), today announced that its payments volume for the 12 months ended December 31, 2023 reached $9.9 billion, a 36% increase over...
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
WINTER SPRINGS, Fla., Jan. 02, 2024 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging ("MRI") compatible medical devices, today announced that the Company will be participating in the upcoming 42nd...
SenesTech Signs Expanded Distribution Agreement for Evolve™ Soft Bait Sales into the United Arab Emirates (UAE)
UAE Expansion Continues Regional Strategy working with Pesterminators PHOENIX, Jan. 2, 2024 -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces the expansion of its...
Mogo repurchases 4.4% of outstanding shares since June 2022
Company repurchased a total of 474,353 shares in 2023 and 600,000 shares in 2022 1.7 million additional shares (or 7% of outstanding shares) remain authorized for repurchase until March 21, 2024 VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo"...
ARIANNE PHOSPHATE MOVES CORPORATE HEADQUARTERS
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQX (USA) SAGUENAY, QC, Dec. 29, 2023 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTCQX: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul...
Zoomd Technologies Announces Results of Annual General Meeting of Shareholders, Re-Electing All Members of the Board of Directors
VANCOUVER, BC, Dec. 29, 2023 /CNW/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the online advertising management platform, announced today the results of its annual general...
Modular Medical Announces Collaboration with Glooko
SAN DIEGO, CA / December 21, 2023 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today...
Aquafil Ranked First Among Global Companies in the “textiles” Subindustry According to Morningstar Sustainalytics Esg Risk Rating
Arco, Italy, Dec. 20, 2023 -- AQUAFIL RANKED FIRST AMONG GLOBAL COMPANIES IN THE "TEXTILES" SUBINDUSTRY ACCORDING TO MORNINGSTAR SUSTAINALYTICS ESG RISK RATING Arco, December 20, 2023 - Aquafil S.p.A. [ECNL:IM] [ECNLF:OTCQX] ranked as the top company globally in the...
NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer
CARMEL, Ind., Dec. 20, 2023 -- NeurAxis, Inc. (NYSE American: NRXS) ("NeurAxis" or the "Company"), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today issued a letter to...
ChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen®
Tru Niagen is now available to US troops through an exclusive Military program LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, is proud to announce its inaugural initiative to...
Noble Capital Markets Initiates Coverage on Cadrenal Therapeutics with Outperform Rating and US$4.00 Price Target
PONTE VEDRA, Fla., Dec. 19, 2023 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes and deaths due to blood...
S&W Seed Company Appoints Jeffrey Rona to Its Board of Directors
LONGMONT, Colo., Dec. 19, 2023 -- S&W Seed Company (Nasdaq: SANW), a global agricultural technology company, today announced the nomination of senior biotechnology executive Jeffrey Rona to its Board of Directors. Mr. Rona has more than 30 years of experience as a...
SenesTech Announces Exclusive Distribution Agreement and Initial Order for Evolve™ Soft Bait in Hong Kong and Macau
Further Expansion to Mainland China is Contemplated in the Agreement PHOENIX, Dec. 18, 2023 -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces entry into a Distribution...
SenesTech Receives Substantial Orders for EVOLVE Soft Bait
The first and only soft bait contraceptive for rats with little or no risk to human health or the environment. PHOENIX, Dec. 14, 2023 -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations,...
Cadrenal Therapeutics Engages The Sage Group to Advance Tecarfarin’s Late-Stage Development and Commercialization
PONTE VEDRA, Fla., Dec. 12, 2023 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) a biopharmaceutical company developing tecarfarin, a late-stage, novel, oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes and deaths (due to...
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
WINTER SPRINGS, Fla., Dec. 12, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today that its Board of Directors approved a special cash dividend of $0.48 per share and the initiation of a regular quarterly dividend on the Company's outstanding...
Registration Is Now Open For Tribe Public’s Webinar Event “Diabetes Care For The Rest Of Us.” Featuring Modular Medical CEO On Friday, December 15, 2023
Meet with Modular Medical CEO, Jeb BesserThere are more than 3 million individuals who use daily insulin to help with the care of Diabetes in the US. 100% of patient population require daily insulin injection. Only 20% currently use an insulin pump.Discover how...
Reviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum
CUPERTINO, Calif., Dec. 11, 2023 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...